Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects

Journal of Asthma

Volumn 47, Issue 4, 2010, Pages 429-433

  Anderson, Sandra D ^a   Brannan, John D ^a   Perry, Clare P ^a   Caillaud, Corinne ^b   Seale, J Paul ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

Area under the curve; Mannitol; Montelukast; Percent protection; Sodium cromoglycate

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE; INTAL SPINCAPS; MANNITOL; MONTELUKAST; PLACEBO; SALBUTAMOL; SALMETEROL XINAFOATE; TERBUTALINE SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EVENING DOSAGE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST;

ACETATES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CROMOLYN SODIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MANNITOL; QUINOLINES;

EID: 77953329105     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903584043     Document Type: Article

References (23)

1. Howell JBL, Altounyan REC. A double blind trial of disodium cromoglycate in the treatment of allergic asthma. Lancet 1967; 2:539-542.
2. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90:421-429.
3. Sheard P, Blair AMJN. Disodium cromoglycate: activity in three in vitro models of the immediate hypersensitivity reactions in lung. IntArchAllergy Appl Immunol 1970; 38:217-224.
4. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulatingmediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 1985; 132:986-992.
5. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984; 130:86-91. (Pubitemid 14092987)
6. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandinD2 and leukotriene C in response to hyperosmolar stimulation of mast cells. Allergy 2006; 61:1473-1479.
7. Brannan JD, GullikssonM, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003; 22:491-496.
8. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006; 27:944-950.
9. Brannan JD, Anderson SD, Gomes K, King GG, Chan H-K, Seale JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 2001; 163: 1420-1425.
10. Currie GP, Haggart K, Lee DKC, Fowler SJ, Wilson AM, Brannan JD, Anderson SD, Lipworth BJ. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 2003; 33: 783-788.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6:5-40.
12. Anderson SD, Brannan J, Spring J, SpaldingN,Rodwell LT,ChanK,Gonda I, Walsh A, Clark AR. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156:758-765.
13. Siddiqui S, Mistry V, Doe C, Roach K, Morgan A, Wardlaw A, Pavord I, Bradding P, Brightling C. Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol 2008; 122:335-341.
14. Spooner C, Spooner G, Rowe B. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev 2003; 4:CD002307.
15. Tullett WM, Tan KM, Wall RT, Patel KR. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax 1985; 40:41-44.
16. Phillips GD, Holgate S. Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. J Appl Physiol 1989; 66:304-312.
17. Flint KC, Leung KBP, Pearce FL, Hudspith BN, Brostoff J, Johnson NM. The hyperosmolar release of histamine from bronchoalveolar mast cells and its inhibition by sodium cromoglycate. Thorax 1985; 40:717.
18. Alton EWFW, Kingsleigh-Smith DJ, Munkonge FM, Smith SN, Lindsay ARG, Gruenart DC, Jeffery PK, Norris A, Geddes DM, Williams AJ. Asthma prophylaxis agents alter the function of an airway epithelial chloride channel. Am J Respir Cell Mol Biol 1996; 14:380-387.
19. Anderson SD, Rodwell LT, Daviskas E, Spring JF, du Toit J. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: a role for the airway epithelium. J Allergy Clin Immunol 1996; 98:S124-134S.
20. Dahĺen S-E, Kumlin M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 2004; 59:453-455.
21. Moloney ED, Griffin S, Burke CM, Poulter LW, O'Sullivan S. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med 2003; 97:1-5.
22. Kersten ETG, Driessen JMM, Van Der Berg JD, Thio BJ. Mannitol and exercise challenge tests in asthmatic children. Pediatr Pulmonol 2009; 44:655-661.
23. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W,Kuna P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008; 121:383-389.